During the past decade, Kaiser Permanente Division of Research conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Division of Research" #1 sponsor was "Kaiser Permanente" with 18 trials, followed by "Radiation Therapy Oncology Group" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "TaiMed Biologics Inc." with 2 trials sponsored and "University of California, San Francisco" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Division of Research" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 4 trials as a collaborator, "Kaiser Permanente" with 3 trials as a collaborator and "National Center for Complementary and Integrative Health (NCCIH)" with 3 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Division of Research" are "Prostate Cancer" (4 trials), "HIV" (3 trials), "Anxiety" (2 trials), "Breast Cancer" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Kaiser Permanente Division of Research" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Division of Research" are "Behavioral" (11 trials), "Drug" (8 trials), "Other" (7 trials), "Radiation" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Lifestyle Counseling" (2 trials), "Usual care" (2 trials), "ibalizumab" (2 trials) and "36.25 Gy IMRT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Division of Research" are 22 trials for "All" genders, 11 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 13 active trials in "Kaiser Permanente Division of Research". 1 are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in Kaiser Permanente Division of Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Division of Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 15 trials that are defined as “Not Applicable".